Abstract
The high-throughput screening core at the University of Minnesota is part of the Institute for Therapeutics Discovery and Development (ITDD), a comprehensive drug discovery and development center. The Institute provides scientific services to both academic and business communities and supports translational medicine via collaborations and contractual work. The ITDD is well-known for its broad range of screening capabilities and offers extensive medicinal chemistry expertise along with GMP scale-up and pre-clinical pharmacology support.
Keywords: Drug development, drug discovery, good manufacturing practices (GMP), high throughput screening (HTS), medicinal chemistry, pharmacology, scale-up, translational science.